Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure
Public ClinicalTrials.gov record NCT03554759. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational Cohort Study of the Use of Avatrombopag in Patients With Thrombocytopenia Associated With Chronic Liver Disease Undergoing a Procedure
Study identification
- NCT ID
- NCT03554759
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Sobi, Inc.
- Industry
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
- Avatrombopag Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2018
- Primary completion
- Jan 30, 2019
- Completion
- Jan 30, 2019
- Last update posted
- Oct 20, 2024
2018 – 2019
United States locations
- U.S. sites
- 41
- U.S. states
- 20
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dova Site | Chandler | Arizona | 85224 | — |
| Dova Site | Lancaster | California | 93534 | — |
| Dova Study Site | Los Angeles | California | 90048 | — |
| Dova Site | Palm Springs | California | 92262 | — |
| Dova Study Site | Pasadena | California | 91107 | — |
| Dova Study Site | San Clemente | California | 92673 | — |
| Dova Study Site | San Diego | California | 92114 | — |
| Dova Study Site | San Diego | California | 92121 | — |
| Dova Study Site | Aurora | Colorado | 80045 | — |
| Dova Study Site | Englewood | Colorado | 80113 | — |
| Dova Study Site | Gainesville | Florida | 32610 | — |
| Dova Study Site | Miami | Florida | 33136 | — |
| Dova Study Site | Atlanta | Georgia | 30309 | — |
| Dova Study Site | Topeka | Kansas | 66606 | — |
| Dova Study Site | Louisville | Kentucky | 40202 | — |
| Dova Study Site | Baltimore | Maryland | 21202 | — |
| Dova Study Site | Boston | Massachusetts | 02215 | — |
| Dova Study Site | Burlington | Massachusetts | 01805 | — |
| Dova Study Site | Worcester | Massachusetts | 01655 | — |
| Dova Study Site | Ann Arbor | Michigan | 48109 | — |
| Dova Study Site | Detroit | Michigan | 48239 | — |
| Dova Site | Jackson | Mississippi | 39216 | — |
| Dova Study Site | New Brunswick | New Jersey | 08901 | — |
| Dova Study Site | Manhasset | New York | 11030 | — |
| Dova Study Site | New York | New York | 10016 | — |
| Dova Study Site | The Bronx | New York | 10467 | — |
| Dova Study Site | Durham | North Carolina | 27710 | — |
| Dova Study Site | Cleveland | Ohio | 44016 | — |
| Dova Study Site | Columbus | Ohio | 43210 | — |
| Dova Study Site | Flourtown | Pennsylvania | 19031 | — |
| Dova Site | Philadelphia | Pennsylvania | 19141 | — |
| Dova Study Site | Pittsburgh | Pennsylvania | 15213 | — |
| Dova Study Site | Johnson City | Tennessee | 37604 | — |
| Dova Study Site | Memphis | Tennessee | 38104 | — |
| Dova Study Site | Union City | Tennessee | 38261 | — |
| Dova Study Site | Dallas | Texas | 75234 | — |
| Dova Study Site | Houston | Texas | 77030 | — |
| Dova Study Site | Charlottesville | Virginia | 22908 | — |
| Dova Study Site | Richmond | Virginia | 23226 | — |
| Dova Study SIte | Roanoke | Virginia | 24014 | — |
| Dova Study Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03554759, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2024 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03554759 live on ClinicalTrials.gov.